About Arbitrant
Clinical intelligence infrastructure built on the belief that the most important biotech opportunities are hiding in plain sight — underserved indications, overlooked patient populations, and regulatory gaps that compound annually.
Information asymmetry is alpha in biotech.
ClinicalTrials.gov registers over 470,000 trials. FDA publishes designation grants daily. USPTO logs every patent filing. The data is public — but it’s fragmented, unscored, and impossible to synthesize without infrastructure.
Arbitrant builds that infrastructure. Our gap score synthesizes trial density, patient burden, patent proximity, and regulatory pathway eligibility into a single, daily-updated number for every disease indication in our database.
The same infrastructure funds Clincol.org — our nonprofit partner that makes the same FDA data freely accessible to patients.
Built for clinical intelligence at scale.
Arbitrant funds Clincol.org by design — not by charity.
Clincol.org is our 501(c)(3) nonprofit partner. Every Pro and Team subscription directly funds Clincol’s AI compute, hosting, and data pipeline. This isn’t a CSR initiative — it’s a structural economic design.
Visit Clincol.org →Contact Arbitrant
For enterprise, partnership, press, or academic pricing inquiries.